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Abstract
Background: Monosodium urate (MSU) has been shown to promote inflammasome activation and interleukin-1b
(IL-1b) secretion in monocyte/macrophages, but the cellular pathway and nod-like receptor family, pyrin domain
containing 3 (NLRP3) inflammasome activation in synovial tissues, remain elusive. In this study, we investigated the
effects of MSU on synovial fibroblasts to elucidate the process of MSU-mediated synovial inflammation.
Methods: Human synovial fibroblasts were stimulated with MSU in the presence or absence of serum amyloid A
(SAA). The cellular supernatants were analyzed by immunoblotting using anti-IL-1b or anti-caspase-1 antibodies. IL-
1b or NLRP3 mRNA expressions were analyzed by real-time PCR or reverse transcription-PCR (RT-PCR) method.
Results: Neither SAA nor MSU stimulation resulted in IL-1b or interleukin-1a (IL-1a) secretions and pro-IL-1b
processing in synovial fibroblasts. However, in SAA-primed synovial fibroblasts, MSU stimulation resulted in the
activation of caspase-1 and production of active IL-1b and IL-1a. The effect of SAA on IL-1b induction was
impaired in cells by silencing NLRP3 using siRNA or treating with caspase-1 inhibitor. In addition, SAA induced the
secretion of cathepsin B and NLRP3 mRNA expression in synovial fibroblasts.
Conclusions: Our data demonstrate that exposure of human synovial fibroblasts to SAA promotes MSU-mediated
caspase-1 activation and IL-1b secretion in the absence of microbial stimulation. These findings provide insight into
the molecular processes underlying the synovial inflammatory condition of gout.
Introduction
Gout is a paradigm for acute sterile inflammation that is
triggered by interactions between monosodium urate
(MSU) crystals and inflammatory cells in the joint con-
nective tissues [1]. Interleukin-1b (IL-1b) has been iden-
tified as a pivotal cytokine in gout and MSU crystal-
induced inflammation [2]. IL-1b is induced as an inac-
tive pro-molecule by immune cells, such as macro-
phages and monocytes, and then cleaved into the active
p17 form of IL-1 by caspase-1 [3,4]. Tschopp et al.
demonstrated that MSU is capable of activating the
NLRP3 inflammasome to process and secrete active IL-
1b [5]. These findings suggest that macrophages can
recognize MSU as danger-associated molecular patterns
(DAMPs) in the damaged tissues and release proinflam-
matory IL-1b [6]. Upon activation, NLRP3 binds to the
ASC, which in turn recruits procaspase-1 for activation.
Activated caspase-1 cleaves pro-IL-1b to form the
mature IL-1b [7].
In vitro experiments have shown that triggering of the
inflammasome to process IL-1b is a multistep process.
Lipopolysaccharide, which belongs to pathogen-asso-
ciated molecular patterns (PAMPs), had been shown to
induce IL-1b from human synovial macrophages [8]. In
the absence of a first signal that induces pro-IL-1b, such
as lipopolysaccharide, monocyte/macrophages do not
spontaneously secrete mature IL-1b when stimulated
with NLRP3 ligands [9,10]. Ii proposed that the first
* Correspondence: migita@nmc.hosp.go.jp
1Department of Rheumatology, Nagasaki Medical Center, Kubara 2-1001-1,
Omura, Nagasaki 856-8562, Japan
Full list of author information is available at the end of the article
Migita et al. Arthritis Research & Therapy 2012, 14:R119
http://arthritis-research.com/content/14/3/R119
© 2012 Migita et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
signal modulates the threshold of NLRP3 and the sec-
ond signal activates NLRP3 inflammasome and causes
subsequent caspase-1 activation and IL-1b processing
[11,12]. Recent investigations demonstrated that IL-1b
and IL-1 receptor are key players in MSU-mediated
acute inflammation [13,14]. However, the steps that
associate cellular activity with MSU crystals that induce
inflammasome activation in gouty arthritis are not com-
pletely understood.
Serum amyloid A (SAA) is an acute-phase protein
present in serum. SAA is also known to possess proin-
flammatory properties and to mediate inflammatory dis-
ease pathogenesis [15,16]. It has recently been
demonstrated that b-amyloid fibrils in Alzheimer’s dis-
ease signal through the NLRP3 inflammasome and drive
caspase-1-dependent cleavage of IL-1b [17]. Further-
more, SAA has been shown to induce the expression of
IL-1b and activate the NLRP3 inflammasome via a
cathepsin B- and P2X7-dependent manner [18]. In this
study, we investigated the MSU-mediated NLRP3 activa-
tion process using synovial fibroblasts isolated from
human synovium and adjuvant activity induced by SAA.
Materials and methods
Reagents
Recombinant human SAA was purchased from Pepro-
tech (Rocky Hills, NJ, USA). According to the manufac-
turer, the endotoxin level of the product is 0.1 ng/mg
protein. MSU crystals were purchased from Alexis (Lau-
sen, Switzerland). Polyclonal anti-IL-1b, pro-IL-1b and
anti-cleaved caspase-1 (D57A2) antibodies were pur-
chased from Cell Signaling Technology (Beverly, MA,
USA). Anti-caspase-1 polyclonal antibodies (sc-622)
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA, USA). Anti-NLRP3 antibodies were obtained
from Abcam (Cambridge, UK). Anti-cathepsin B antibo-
dies and caspase-1 inhibitor (z-YVAD-FMK) were
obtained from Calbiochem (San Diego, CA, USA)
Preparation of synovial fibroblasts
Synovial tissues were obtained from patients with rheu-
matoid arthritis at the time of total joint replacement.
Synovial fibroblasts were isolated from the synovial tis-
sues by enzymatic digestion. The study was approved by
the Ethics Committees Nagasaki Medical Center and
informed consent was obtained from each of the indivi-
duals. Synovial fibroblasts were used from passages 4
through 6 during which time they are a homogeneous
population of cells (<1% CD 45 positive).
Measurement of cytokine secretion and immunoblot
analysis
Synovial fibrablasts (5 × 104) were seeded in 24-well
plates containing RPMI1640 supplemented with 10%
heat-inactivated FBS and stimulated with MSU for 24
hours. In some experiments, synovial fibrablasts were
pre-treated with SAA for 12 hours before stimulation.
Cell-free supernatants were collected by centrifugation
at 400 g for five minutes and assayed for IL-1b or IL-
1a with enzyme-linked immunosorbent assay (ELISA)
kits (R&D Systems, Minneapolis, MN, USA) without
the steps for concentrations or precipitations. The
same supernatants were also subjected to 12% SDS-
PAGE, followed by immunoblotting with Abs for
human IL-1b (dilution 1:400), caspase-1 (dilution
1:500), and cathepsin B (dilution 1:500) with an ECL
Western blotting kit (Amersham, Little Chalfont, UK).
Endotoxin was measured by chromogenic limulus test
(Toxicolor LS-50M Kit, SEIKAGAKU CORPORA-
TION, Tokyo, Japan).
Small interfering RNA experiments
Synovial fibroblasts were transfected with 100 nM non-
targeting control small interfering RNA (siRNA; AllStars
Negative Control siRNA; Qiagen, Hilden, Germany) or
with 50 nM two NLRP3 siRNAs (CIAS1_6 and
CIAS1_9; Qiagen), combined with the HiPerFect Trans-
fection Reagent (Qiagen) under serum-free condition, as
instructed by the manufacturer. The medium was subse-
quently replaced, pretreated with SAA for 12 h and sti-
mulated with another 24 h with MSU with medium
containing 10% FBS. The cell-culture medium was col-
lected for IL-1b ELISA analysis. In some experiments
cells were harvested for total RNA purification after
SAA pretreatment and analyzed by semi-quantitative
RT-PCR (NLRP3), as described below.
Reverse transcription-polymerase chain reaction (RT-PCR)
Total RNA was extracted from synovial fibroblasts using
the RNeasy total RNA isolation protocol (Qiagen, Crau-
ley, UK) according to the manufacturer’s protocol. First-
strand cDNA was synthesized from 1 μg of total cellular
RNA using an RNA PCR kit (Takara Bio Inc., Otsu,
Japan) with random primers. Thereafter, cDNA was
amplified using specific primers respectively. The speci-
fic primers used were as follows:
NLRP3: forward primer 5’- AAAGAGATGAGCC-
GAAGTGGG -3’ reverse primer 5’-
TCAATGCTGTCTTCCTGGCA -3’ b-actin; forward
primer 5’-GTGGGGCGCCCCAGGCACCA-3’ reverse
primer 5’-CTCCTTAATGTCACGCACGATTTC-3’.
The product sizes were 79 bp for NLRP3 and 234 bp
for b-actin. The thermocycling conditions (35 cycles)
94°C for 60 s and 62°C for 60 s, and 72°C for 60 s.
The amplification of the IL-1-b transcripts was also
accomplished on a Light Cycler (Roche Diagnostics,
Mannheim, Germany) using specific primers. The
housekeeping gene fragment of glyceraldehydes-3-
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phosphates dehydrogenase (GAPDH) was used for veri-
fication of equal loading.
Cell lysis and immunoblot
Synovial fibroblasts were stimulated with SAA with the
indicated concentrations of SAA for 24 h. Cells were
washed by ice-cold PBS and lysed with a lysis buffer (1%
Nonidet P 40, 50 mM Tris, pH 7.5, 100 mM NaCl, 50
mM NaF, 5 mM EDTA , 20 mM b-glycerophosphate,
1.0 mM sodium orthovanadate, 10 μg/mL aprotinin and
10 μg/mL leupeptin) for 20 minutes at 4°C. Insoluble
material was removed by centrifugation at 15,000 × g
for 15 minutes at 4°C. The supernatant was saved and
the protein concentration was determined using the
Bio-Rad protein assay kit (Bio Rad, Hercules, CA, USA).
An identical amount of protein (50 μg) for each lysate
was subjected to 10% SDS-polyacrylamide gel electro-
phoresis, and then transferred to a nitrocellulose mem-
brane. Immunoblot analysis using anti-NLRP3, pro-IL-b
and b-acitin antibodies was performed with an ECL
Western blotting kit (GE Healthcare, BUCKS, UK). In
brief, the membrane was probed with primary antibodies
and washed and incubated with donkey anti-rabbit sec-
ondary antibody conjugated with horseradish peroxidase
(1:10,000 diluation; GE Healthcare). After being washed,
the membrane was reacted with an ECL advance Wes-
tern blot detection kit (GE Healthcare). Protein bands
were visualized using a lumino-image analyzer
(LAS3000; Fujifilm, Toyo, Japan).
Statistical analysis
Differences between groups were examined for statistical
significance using Wilcoxon-Mann-Whitney U test. P-
values less than 0.05 were considered statistically
significance.
Results
SAA priming induces mature IL-1b secretion from MSU-
treated synoval fibroblasts
SAA has been shown to induce the expression of var-
ious proinflammatory cytokines in inflammatory cells.
First, we examined whether SAA induces IL-1b secre-
tion from synovial fibroblasts. As shown in Figure 1,
SAA is a potent inducer of pro-IL-1b mRNA expression
in synovial fibroblasts. However, SAA alone did not
induce the secretion of IL-1b, suggesting that SAA
alone is not able to provide the signal for the proteolytic
cleavage of pro-IL-1b and secretion of mature IL-1b
(Figure 2A). In contrast, priming of synovial fibroblasts
with SAA resulted in the induction of IL-1b secretion
when these cells were subsequently stimulated with
MSU (Figure 2A). Immunoblot analysis also indicated
that in addition to pro-IL-1b (31 kDa), cleaved mature
IL-1b (17 kDa) was also induced by MSU in SAA-
primed synovial fibroblasts (Figure 2B).
Endotoxin contamination dose not contribute to the IL-1b
induction by SAA/MSA
We next determined whether the induction of IL-1b is a
direct effect of SAA or results from contaminating LPS
in the SAA preparation. LPS priming induce the IL-1b
secretion following MSU stimulation from synovial
fibroblasts; however, its IL-1b-inducing ability was lower
compared to those of SAA-priming (Figure 3A). Given
that most proteins are heat-labile, whereas LPS is heat-
resistant, we examined the ability of heat-treated SAA
Figure 1 SAA induces the transcription of pro-IL-1b in human synovial fibroblasts. A. Synovial fibroblasts were incubated with SAA (2 μg/
ml) for the indicated periods. The cells were harvested and analyzed for pro-IL-1b mRNA levels by real-time PCR. B. Synovial fibroblasts were
incubated with the indicated concentrations of SAA for 6 h. The cells were harvested and analyzed for IL-1b and GAPDH mRNA levels by real-
time PCR. Values represent the mean ± SD of three independent experiments.*P <0.001 compared to SAA-untreated synovial fibroblasts.
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(1 μg/ml) and LPS (500 pg/ml) to stimulate IL-1b secre-
tion from synovial fibroblasts. As shown in Figure 3B,
after heating 100°C for 30 minutes, LPS retained its abil-
ity to induced MSU-stimulated IL-1b production. In
contrast, SAA exposed to 100°C for 30 minutes could
not stimulate IL-1b secretion completely as described
previously [19]. The endotoxin detected by limulus test
was extremely high in LPS-primed synovial fibroblasts-
conditioned media, whereas, endotoxin was not detected
SAA-primed synovial fibroblast-conditioned media (Fig-
ure 3B). These results indicate that the trace amount of
LPS in the SAA preparation cannot account for the IL-
1b secretion from SAA/MSU-stimulated synovial
fibroblasts.
SAA/MSU-induced IL-1b processing is dependent on
caspase-1
Previous investigations demonstrated that the inflamma-
tory caspases are cleaved and released along with active
IL-1b after activation of the inflammasome [20]. Consis-
tent with these findings, SAA/MSU stimulation activated
caspase-1 in synovial fibroblasts (Figure 4A). The cas-
pase-1 dependency for the pro-IL-1b processing was
confirmed by addition of the caspase-1 inhibitor z-
YVAD-fmk, which completely blocked SAA/MSU-
induced IL-1b processing (Figure 4B).
SAA induces NLRP3 expression and cathepsin B release in
synovial fibroblasts
The induction of NLRP3 expression is important for
inflammasome activation [21]. Therefore, we examined
the effects of SAA on NLRP3 expression in synovial
fibroblasts. As shown in Figure 5A, a rapid increase in
NLRP3 mRNA expression was observed in SAA-stimu-
lated synovial fibroblasts. Also, we analyzed the protein
expressions of pro-IL-1b and NLRP3 using the lysates
of SAA-stimulated synovial fibroblasts. Immunoblot
analysis revealed the protein expressions of pro-IL-1b
and NLRP3 were increased by SAA stimulation (Figure
5B). To elucidate the role of NLRP3 in SAA/MSU-
induced IL-1b induction, NLRP3 was silenced in syno-
vial fibroblasts using a combination of two small inter-
fering RNAs (siRNA). The siRNA treatments
prevented SAA-induced NLRP3 mRNA expression
(Figure 5C). Silencing the NLRP3 gene reduced SAA/
MSU-induced IL-1b secretion, while no inhibition of
IL-1b secretion was observed in synovial fibroblasts
transfected with negative control siRNA (Figure 5D).
Inflammasome activation has been associated with the
release of cathepsin B from the cells [22,23]. Therefore,
we examined the cell-free culture media for the pre-
sence of cathepsin B. As shown in Figure 6, significant
secretion of cathepsin B was observed in SAA/MSU-
stimulated synovial fibroblasts, as well as SAA-primed
synovial fibroblasts.
SAA priming induces IL-1a secretion from MSU-treated
synoval fibroblasts
More recently, IL-1a secretion was demonstrated to be
required the presence of IL-1b, in which IL-1b directly
binds IL-1a as a shuttle [24]. Therefore, we examined
whether SAA/MSU stimulation induces IL-1a secretion
from rheumatoid synovial fibroblasts. Although neither
SAA nor MSU induces IL-1a secretion, SAA priming
induces the IL-1a secretion from MSU-stimulated syno-
vial fibroblasts parallel to IL-1b secretion (Figure 7).
Figure 2 MSU induces IL-1b synthesis from SAA-primed synovial fibroblasts. A. Synovial fibroblasts were pretreated or untreated with the
indicated concentrations of SAA for 12 h. After pretreatment, the cells were stimulated with the indicated concentrations of MSU for 24 h and
supernatants were analyzed for IL-1b production by ELISA. Values represent the mean ± SD of three independent experiments. B. Synovial
fibroblasts were pretreated or untreated with the indicated concentrations of SAA for 12 h. After pretreatment, the cells were stimulated with
the indicated concentrations of MSU for 24 h and supernatants were analyzed by immunoblot for the presence of mature IL-1b. Three
experiments were performed using different synovial fibroblasts and a representative result is shown.
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Discussion
Gout is a form of inflammatory arthritis caused by for-
mation of MSU crystals in the synovial tissues of joints
[1]. IL-1b has been identified as a pivotal cytokine in
gout and MSU crystal-induced inflammation [25].
Recent studies suggested that MSU-mediated NLRP3
inflammasome activation and subsequent IL-1b produc-
tion in macrophages as key events in initiation of gout
[2]. The aim of this study was to determine whether
MSU-mediated inflammasome activation could be
induced in non-myeloid synovial fibroblasts. A variety of
structurally diverse molecules, including ATP, bacterial
toxins, crystals, and amyloid proteins, are known to acti-
vate the NLRP3 inflammasome leading to IL-1b secre-
tion [26]. Here we found that SAA, which is
endogenously induced as an acute phase reactant,
sensed the MSU-mediated caspase-1 activation and pro-
IL-1b processing. The NLRP3 inflammasome pathway
should be pivotal in this SAA/MSU-mediated IL-1b
induction, since silencing NLRP3 using siRNA resulted
in the abortive IL-1b induction. These data implicate a
casual role of SAA in the pathogenesis of MSU-
mediated inflammasome activation as well as acute
inflammation seen in gouty arthritis.
IL-1b requires cleavage via caspase-1 for proper secre-
tion, which is facilitated as a consequence of inflamma-
some assembly and activation [26]. The NLRP3
inflammasome has emerged as a critical sensor for a
number of endogenous mediators, including MSU, that
are capable of promoting IL-1b secretion [25]. However,
our study demonstrated that MSU alone did not induce
caspase-1 activation or IL-1b secretion in human syno-
vial fibroblasts. Because of its pro-IL-1b inducing effect,
SAA-priming of synovial fibroblasts could be essential
for MSU-induced IL-1b secretion. Our data also suggest
that SAA-induced NLRP3 mRNA expression and cathe-
psin B secretion may contribute to MSU-mediated
NLRP3 activation.
Several lines of evidence indicate that toll-like receptor
(TLR) ligands can elicit inflammasome activation [27].
Figure 3 Endotoxin contaminution dose not contribute to IL-1b induction by SAA/MSU. A. Synovial fibroblasts were pre-treated with SAA
(1 μg/ml) or LPS (500 pg/ml) for 12 h. Cells were stimulated with MSU (200 μg/ml) for 24 h. Supernatants were analyzed for IL-1b production by
ELISA. Values represent the mean ± SD of two independent experiments. P <0.01 compared to SAA-untreated synovial fibroblasts. B. Synovial
fibroblasts were pre-treated with SAA (1 μg/ml) or LPS (500 pg/ml), which were exposed to 100°C (heat) in a water bath for 30 minutes, for 12
h. Cells were stimulated with MSU (200 μg/ml) for 24 h. Supernatants were analyzed for IL-1b production by ELISA. The endotoxin levels were
also measured by limulus test using the same supernatants. Values represent the mean ± SD of two independent experiments.
Figure 4 SAA/MSU-induced IL-1b processing is dependent on caspase-1. A. Synovial fibroblasts were untreated or pretreated with SAA (2
μg/ml) for 12 h. Cells were stimulated with the indicated concentrations of MSU for 24 h. Supernatants were analyzed by immunoblot for the
presence of procaspase-1 (p45) and cleaved caspase (p20). Three experiments were performed using different synovial fibroblasts and a
representative result is shown. B. Synovial fibroblasts were untreated or pretreated with SAA (2 μg/ml) for 12 h. Cells were stimulated with MSU
in the presence or absence of z-YVAD-fmk (10 μM) for 24 h. Supernatants were analyzed by immunoblot analysis for the presence of mature IL-
1b. Two experiments were performed using different synovial fibroblasts and a representative result is shown.
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Figure 5 SAA induces NLRP3 expression. A. Synovial fibroblasts were stimulated with SAA (2 μg/ml) for 12 h. The cells were analyzed for
NLRP3 mRNA by RT-PCR. Three experiments were performed using different synovial fibroblasts and a representative result is shown. B. Synovial
fibroblasts were stimulated with the indicated concentrations of SAA for 24 h. Cellular lysates were subjected to Western blotting using specific
antibodies against NLRP3, pro-IL-1b and b-actin (internal control). Three experiments were performed and a representative result is shown. C.
Synovial fibroblasts were transfected with non-targeting control siRNA or NLRP3 siRNA for 22 h and subsequently stimulated with SAA (2 μg/ml)
for 12 h. The cells were analyzed for NLRP3 mRNA by RT-PCR. Three experiments were performed using different synovial fibroblasts and a
representative result is shown. D. The transfected cells as described in C were pretreated with SAA (2 μg/ml) for 12 h and subsequently
stimulated with MSU (200 μg/ml) for 24 h. Cell-free culture supernatants were analyzed for IL-1b by ELISA. Values represent the mean ± SD of
three independent experiments. *P <0.01 compared to control siRNA transfected synovial fibroblasts.
Figure 6 SAA induces the secretion of cathepsin B from synovial fibroblasts. Synovial fibroblasts were untreated or pretreated with SAA (2
μg/ml) for 12 h and subsequently stimulated with of MSU (200 μg/ml) for 24 h. Supernatants were analyzed by immunoblot analysis for
presence of cathepsin B. Three experiments were performed using different synovial fibroblasts and a representative result is shown.
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Our findings suggest that SAA, a non-bacterial endo-
genous product, is sufficient to trigger caspase-1 activa-
tion and IL-1b processing in response to MSU,
providing a mechanism for activation of the NLRP3
inflammasome in human synovial tissues. Endogenous
molecules may be the first signal to prime the activation
of the NLRP3 inflammasome, resulting in cooperative
signaling [28]. The second signal is provided by stimuli
that specifically activate NLRP3 and leads to caspase 1
activation and IL-1b processing [28]. Our results suggest
that an endogenous proinflammatory molecule, SAA,
could be the first signal to prime the activation of the
NLRP3 inflammasome.
Conclusion
Our data indicate that SAA induced MSU-mediated
NLRP3 inflammasome activation and post-transla-
tional processing of IL-1b in human synovial fibro-
blasts. These findings highlight the potential role of
SAA, a highly sensitive acute phase reactant, in the
triggering of MSU-mediated acute synovial inflamma-
tion. The innate immune systems, including TLRs, are
thought to be essentially involved in inflammasome-
mediated inflammation [27]. However, our data show
that interaction of an endogenous and non-bacterial
acute phase protein, SAA, and MSU crystals synergis-
tically enhance the inflammatory response by activat-
ing the inflammasome pathway. These findings
provide a new insight into the mechanisms underlying
acute gout.
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